Lishomwa C. Ndhlovu - 24 Nov 2021 Form 3 Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-in-Fact
Issuer symbol
CYDY
Transactions as of
24 Nov 2021
Net transactions value
$0
Form type
3
Filing time
13 Dec 2021, 18:13:29 UTC
Next filing
08 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYDY Stock Option (right to buy) 24 Nov 2021 Common Stock 50,000 $3.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became exercisable as to 25,000 shares on the date of grant, August 31, 2020, and as to the remaining 25,000 shares on February 28, 2021.

Remarks:

EX 24- Power of Attorney